Lars V. Heumann
13Patents
5h-index
92Co-inventors
65Inventor score
Filing activity: Jul 20, 2010 → Jan 20, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10836787B2 | Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5- (4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy) phosphoryl)amino)propanoate | Emerging Cross-Sectional Technologies | 28 | Active |
| US11344565B2 | Methods for the preparation of ribosides | Emerging Cross-Sectional Technologies | 18 | Active |
| US11597742B2 | Crystalline forms of (S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate | Emerging Cross-Sectional Technologies | 17 | Active |
| US11613553B2 | Methods of preparing 1′-cyano nucleosides | Chemistry; Metallurgy | 16 | Active |
| US8816122B2 | Prostratin analogs, bryostatin analogs, prodrugs, synthetic methods, and methods of use | Chemistry; Metallurgy | 5 | Active |
| US12030906B2 | Crystalline forms of (s)-2-ethylbutyl 2-(((s)-(((2r,3s,4r,5r)-5-(4-aminopyrrolo[2,1-f] [1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy) (phenoxy) phosphoryl)amino)propanoate | Emerging Cross-Sectional Technologies | 4 | Active |
| US9890134B2 | Processes for preparing antiviral compounds | Chemistry; Metallurgy | 4 | Active |
| US9670187B2 | Processes for preparing antiviral compounds | Chemistry; Metallurgy | 3 | Active |
| US10584109B2 | Processes for preparing antiviral compounds | Chemistry; Metallurgy | 2 | Active |
| US10736883B2 | Triazole furan compounds as agonists of the APJ receptor | Chemistry; Metallurgy | 1 | Active |
| US11760746B2 | Methods and intermediates for preparing therapeutic compounds | Chemistry; Metallurgy | 1 | Active |
| US11046680B1 | Heteroaryl-substituted triazoles as APJ receptor agonists | Chemistry; Metallurgy | 1 | Active |
| US11192875B2 | Processes for preparing antiviral compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.